In summary, our study discloses both SEPT2 and SEPT7 are essential for breast cancer cell migration and invasion by controlling MEK/ERK MAPKs activation and also suggests the targeting septin proteins might be a novel direction for breast cancer therapy. Here, MAP2K7 is linked to breast cancer.